97.94USD-1.53%Mkt Cap: 6.36B USDP/E: 23.32Last update: 2026-06-01
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers …
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap6.36B USD
Enterprise Value6.59B USD
Revenue (TTM)1.55B USD
Gross Profit941.95M USD
Net Income (TTM)233.56M USD
Revenue/Share23.25 USD
Last Price97.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS5165441032
Valuation
P/E (Trailing)23.32
P/E (Forward)15.58
PEG—
EV/EBITDA18.00
EV/Revenue4.26
P/S4.18
P/B5.33
EPS (TTM)4.19
EPS (Forward)6.37
52W Range
47.2589% of range103.89
52W High103.89 USD
52W Low47.25 USD
Profitability
Gross Margin61.10%
Oper. Margin21.65%
EBITDA Margin23.69%
Profit Margin15.15%
ROE21.43%
ROA10.49%
Growth
Revenue Growth1.20%
Earnings Growth76.50%
Cash Flow & Leverage
Operating CF390.14M USD
CapEx (TTM)41.50M USD
FCF Margin27.27%
FCF Yield6.63%
Net Debt127.17M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.57
Current Ratio2.83
Quick Ratio2.57
Book Value/Sh18.63 USD
Cash/Share7.658 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Strong Buy)
Target (Mean)105.23 USD
Target Range76.00 USD – 117.00 USD
# Analysts13
Ownership
Shares Out.65.11M
Float58.38M
Insiders2.09%
Institutions115.61%
Short Interest
Short Ratio7.2d
Short % Float13.16%
Short % Out.9.89%
Shares Short6.44M
Short (prev mo.)5.11M
Technical
SMA 5085.16 (+15.0%)
SMA 20067.43 (+45.3%)
Beta-0.08
S&P 52W Chg27.94%
Avg Vol (30d)942.49K
Avg Vol (10d)1.19M
Technical Indicators
RSI (14)65.2
MACD4.2294
MACD Signal4.0494
MACD Hist.+0.1800
BB Upper104.53 USD
BB Middle94.30 USD
BB Lower84.08 USD
BB Width21.69%
ATR (14)3.503 USD
Vol Ratio (20d)0.86x